Ligand Pharmaceuticals (LGND) Net Margin Growth (1y) (2011 - 2026)
Ligand Pharmaceuticals (LGND) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ligand Pharmaceuticals |
5.47 Bn |
4.69 Bn |
48.45 Mn |
6,784.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
6,784.00 |
| Dec 31, 2025 |
14,767.00 |
| Mar 31, 2023 |
294.00 |
| Dec 31, 2022 |
-192.00 |
| Sep 30, 2022 |
-452.00 |
| Jun 30, 2022 |
-1,967.00 |
| Mar 31, 2022 |
328.00 |
| Dec 31, 2021 |
-2,907.00 |
| Sep 30, 2021 |
493.00 |
| Jun 30, 2021 |
-6,057.00 |
| Mar 31, 2021 |
6,277.00 |
| Dec 31, 2020 |
5,241.00 |
| Sep 30, 2020 |
4,546.00 |
| Jun 30, 2020 |
11,103.00 |
| Mar 31, 2020 |
-160,514.00 |
| Dec 31, 2019 |
4,402.00 |
| Sep 30, 2019 |
-20,900.00 |
| Jun 30, 2019 |
-13,896.00 |
| Mar 31, 2019 |
145,174.00 |
| Mar 31, 2016 |
-1,639.00 |
